Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Non Operating Income (2022 - 2025)

Coya Therapeutics' Non Operating Income history spans 4 years, with the latest figure at $317066.0 for Q3 2025.

  • For Q3 2025, Non Operating Income fell 26.07% year-over-year to $317066.0; the TTM value through Sep 2025 reached $1.5 million, up 5.22%, while the annual FY2024 figure was $1.6 million, 157.86% up from the prior year.
  • Non Operating Income for Q3 2025 was $317066.0 at Coya Therapeutics, down from $319541.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $444232.0 in Q4 2024 and bottomed at -$3017.0 in Q1 2022.
  • The 4-year median for Non Operating Income is $174672.0 (2023), against an average of $223896.5.
  • The largest annual shift saw Non Operating Income soared 5523.73% in 2023 before it dropped 26.07% in 2025.
  • A 4-year view of Non Operating Income shows it stood at $16330.0 in 2022, then soared by 969.64% to $174672.0 in 2023, then skyrocketed by 154.32% to $444232.0 in 2024, then fell by 28.63% to $317066.0 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Non Operating Income are $317066.0 (Q3 2025), $319541.0 (Q2 2025), and $370165.0 (Q1 2025).